Unverified50% confidenceFactExact time
Biopharmaceutical R&D has long cycles, high failure rates, and data scattered across laboratory information systems, electronic lab notebooks, and clinical databases.
1
Sources
50%
Confidence
Long-term
Relevance
10/20/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedHigh-quality AI-ready biological data is expected to significantly shorten drug discovery timelines.72% similarUnverifiedProgressing from laboratory discovery to clinical application requires crossing lengthy stages including animal model validation, safety testing, and multi-phase clinical trials, and many early-stage findings ultimately fail to translate into clinical use.67% similarUnverifiedEven if the test results are accurate, if they cannot be seamlessly embedded into electronic medical records and prescription systems, it is difficult for doctors to handle an additional rhythm report in a busy outpatient clinic; therefore, the long-term value of such products may lie not only in the test itself, but in whether they can form a closed loop with hospital information systems, drug delivery pumps, and other devices.67% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1077205API
curl https://kongchang.com/api/v1/knowledge/claims/1077205MCP
get_claim(id=1077205)